User profiles for Heba Altarawneh
Heba AltarawnehMass General Hospital Verified email at mgb.org Cited by 1310 |
[HTML][HTML] Protection against the Omicron variant from previous SARS-CoV-2 infection
HN Altarawneh, H Chemaitelly… - … England Journal of …, 2022 - Mass Medical Soc
Protection against Omicron by Previous SARS-CoV-2 Infection Using a national Covid-19
database in Qatar, investigators found that previous SARS-CoV-2 infection provided protection …
database in Qatar, investigators found that previous SARS-CoV-2 infection provided protection …
[HTML][HTML] Effects of previous infection and vaccination on symptomatic omicron infections
Background The protection conferred by natural immunity, vaccination, and both against
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with the …
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with the …
[HTML][HTML] Protective effect of previous SARS-CoV-2 infection against Omicron BA. 4 and BA. 5 subvariants
Prevention of Omicron by Previous Covid-19 Epidemiologic data from Qatar show that any
previous SARS-CoV-2 infection was 35% effective in preventing reinfection with omicron BA …
previous SARS-CoV-2 infection was 35% effective in preventing reinfection with omicron BA …
[HTML][HTML] Protection against reinfection with the omicron BA. 2.75 subvariant
Effect of Previous SARS-CoV-2 Infection against BA.2.75 Infection A test-negative, case–control
study in Qatar showed that previous infection with pre-omicron strains of SARS-CoV-2 …
study in Qatar showed that previous infection with pre-omicron strains of SARS-CoV-2 …
[HTML][HTML] Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Background Protection against SARS-CoV-2 symptomatic infection and severe COVID-19 of
previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination, and hybrid …
previous infection, mRNA two-dose vaccination, mRNA three-dose vaccination, and hybrid …
Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA. 1 and BA. 2 Omicron infections and severe COVID-19 in Qatar
BACKGROUND Protection offered by five different forms of immunity, combining natural and
vaccine immunity, was investigated against SARS-CoV-2 Omicron symptomatic BA.1 …
vaccine immunity, was investigated against SARS-CoV-2 Omicron symptomatic BA.1 …
Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant
BACKGROUND Natural SARS-CoV-2 infection elicits strong protection against reinfection
with the Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.2) variants. However, the Omicron (…
with the Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.2) variants. However, the Omicron (…
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design
The COVID-19 pandemic has highlighted the need to use infection testing databases to
rapidly estimate effectiveness of prior infection in preventing reinfection ( $P{E}_S$ ) by novel …
rapidly estimate effectiveness of prior infection in preventing reinfection ( $P{E}_S$ ) by novel …
Protection of SARS-CoV-2 natural infection against reinfection with the Omicron BA. 4 or BA. 5 subvariants
This study estimates the effectiveness of previous infection with SARS-CoV-2 in preventing
reinfection with Omicron BA.4/BA.5 subvariants using a test-negative, case–control study …
reinfection with Omicron BA.4/BA.5 subvariants using a test-negative, case–control study …
[HTML][HTML] Systemic inflammation may induce cardiac injury in COVID-19 patients including children and adolescents without underlying cardiovascular diseases: a …
…, F Wahbeh, N Al-Nassr, H Altarawneh… - Cardiovascular …, 2022 - Elsevier
Coronavirus disease 2019(COVID-19) is an ongoing global pandemic with a daily increasing
number of affected individuals and a relatively high mortality rate. COVID-19 patients that …
number of affected individuals and a relatively high mortality rate. COVID-19 patients that …